Backed by New Medical Association Certification, Insumate® Becomes the Only Bitter Melon Peptide Globally Recognized by ...

A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) ...

It’s about co-creating science.” The event highlighted pathogen research discoveries and pandemic prevention efforts from ...

Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced positive results from its completed Phase 2 trial evaluating ...

Precise Bio Inc., a Greensboro-based clinical-stage regenerative medicine company, has announced the world’s first transplant ...

A pioneering treatment that edits healthy immune cells to fight cancer has shown promise for adults and children with a rare ...

With the best-selling medication in the world, tirzepatide, and a record-setting $1 trillion valuation to go with it, Eli ...

The Symbol of National Quality (SNQ), initiated by Taiwan’s Institute for Biotechnology and Medicine Industry (IBMI), has partnered with the International Consortium for Health Outcomes Measurement ...

At this year's ASH congress, the results of the phase 1b/2 DURGA-1 of AZD0120 – a dual BCMA and CD19-directed CAR-T therapy – ...

Investors seeking stocks with explosive growth potential should consider the biotech industry. Drugmakers can experience ...

Massachusetts Institute of Technology professor Phillip Sharp co-founded Alnylam with several others in 2002. It wasn't Sharp ...

Explore the challenges and opportunities in enhancing India's medical research ecosystem to unlock its potential for ...